Creative Touch Permanent Makeup and Aesthetics

Free fatty acids are the third component of the stratum corneum lipid triad, making up approximately 15–25% of the intercellular lipid matrix alongside ceramides and cholesterol. The word “free” distinguishes them from fatty acids bound within ceramide or phospholipid structures: in the extracellular matrix, they exist as unbound molecules integrated into the lamellar phases. Their role is often described simply as filling the spaces between corneocytes, but this understates their function considerably. Free fatty acids contribute directly to lamellar phase architecture, generate the acid mantle that activates the skin’s own ceramide-processing enzymes, and provide the only source of linoleic acid available to the skin for acylceramide construction. ^[10]

Chain Length Determines Function

Not all free fatty acids contribute equally. The stratum corneum contains a specific profile dominated by very long-chain saturated fatty acids, particularly those in the C22–C26 range, including behenic acid (C22:0), lignoceric acid (C24:0), and cerotic acid (C26:0). Research by van Smeden and colleagues at Leiden University demonstrated that the chain length distribution of free fatty acids significantly affects how they mix with ceramides and cholesterol in model membrane systems, with longer-chain saturated fatty acids producing tighter, more ordered lamellar packing. Shorter or more unsaturated fatty acids, which might be introduced through poorly designed formulations or unusual dietary profiles, disrupt this packing. The skin’s preference for very long-chain saturated fatty acids in its barrier matrix is not incidental; it reflects the structural demands of building a water-resistant lamellar architecture rather than simply filling space. ^[10]

This is also why the elongase enzymes, particularly ELOVL1 and ELOVL4, which extend fatty acid chains from C20 upwards toward the ultralong range, are so central to barrier function. They do not just serve ceramide production: they supply the free fatty acid chain lengths the barrier itself requires. ^[8]

The Acid Mantle: FFAs Beyond Structure

Free fatty acids are the primary endogenous source of the stratum corneum’s acidic pH, which sits between approximately 4.5 and 5.5 in healthy skin. They are generated at the skin surface through the action of secretory phospholipase A2, which cleaves free fatty acids from phospholipids. This generates the characteristic fatty acid profile that acidifies the skin surface and creates what is commonly referred to as the acid mantle. ^[6]

The acid mantle performs functions that extend well beyond the immediate antimicrobial environment. Critically, the enzymes responsible for the final conversion of ceramide precursors into active ceramides, specifically acidic sphingomyelinase and beta-glucocerebrosidase, have pH optima of approximately 5. At a neutral or alkaline pH, both enzymes become significantly less active, meaning ceramide production from its precursor pool slows measurably even when synthesis upstream is intact. Research has confirmed that exposure of intact stratum corneum to neutral pH for as little as three hours produces abnormalities in barrier integrity and cohesion, including premature dissolution of desmosomes, the protein structures that hold corneocytes together. ^[4]

Free fatty acids are therefore not merely structural lipids. Their generation directly enables the pH environment in which ceramide processing, microbiome regulation, and barrier cohesion all function. A formulation that raises skin surface pH through alkaline surfactants, or a hard water environment where calcium and magnesium ions react with free fatty acids – particularly stearic acid – to form insoluble calcium stearate deposits, undermines ceramide availability at the same processing step. In the case of hard water, the mechanism is specifically reductive: calcium ions displace hydrogen ions from the carboxylate groups of surface fatty acids, forming an insoluble precipitate that physically strips FFAs from the acid mantle with every wash. This makes FFA depletion the primary mechanism by which hard water disrupts barrier chemistry – not a secondary consequence of pH change, but the direct cause of it. ^[2]

Linoleic Acid: The Essential Fatty Acid the Skin Cannot Make

Among the free fatty acids involved in barrier function, linoleic acid occupies a unique position. It is an omega-6 polyunsaturated fatty acid that human skin cannot synthesise endogenously, meaning it must be supplied through diet or topical application. Its primary structural role in the stratum corneum is not as a free fatty acid in the matrix but as the fatty acid esterified at the omega position of the acylceramides EOS and EOP. Without adequate linoleic acid, these ceramide subtypes cannot form correctly, and the long periodicity phase they generate is directly compromised. ^[5]

In essential fatty acid deficiency, barrier function deteriorates in a pattern specifically characterised by LPP disruption and increased transepidermal water loss, which can be corrected by topical linoleic acid application before systemic fatty acid status is restored. This localised correction confirms that linoleic acid’s barrier role is direct rather than mediated through systemic pathways. In atopic dermatitis, the deficit is not a straightforward shortage of linoleic acid itself, which is often elevated in atopic patients’ blood and tissue, but an impaired conversion of linoleic acid to downstream metabolites via delta-6 desaturase. This enzymatic bottleneck reduces the availability of gamma-linolenic acid (GLA) and its metabolites, with lower GLA metabolite concentrations showing a negative correlation with transepidermal water loss in atopic subjects. ^[7]

Inflammatory Suppression of Elongation

The elongase enzymes that produce the very long-chain fatty acids the stratum corneum requires are directly targeted by the same inflammatory signals that suppress ceramide synthesis. IL-13 inhibits ELOVL3 and ELOVL6 fatty acid elongases through a STAT6-dependent mechanism, measurably reducing the production of long-chain fatty acids in skin with elevated type 2 inflammatory signalling. This is the same cytokine pathway through which atopic conditions, chronic sensitivity, and stress-related skin deterioration undermine ceramide production, which means that the inflammatory suppression of FFA elongation and ceramide synthesis are not independent events – they are coupled failures driven by the same upstream signal. ^[12]

PPAR-α and Dietary FFA Support

The synthesis of free fatty acids in keratinocytes is coordinated in part by peroxisome proliferator-activated receptor alpha ( PPAR-α), a nuclear receptor activated by fatty acid derivatives. When PPAR-α is activated, it upregulates the enzymes involved in free fatty acid production in the stratum corneum, supporting the FFA pool that the acid mantle depends on. ^[11] Omega-3 fatty acids – specifically EPA and DHA – act as PPAR-α ligand activators, making dietary omega-3 supplementation a mechanistically grounded intervention for conditions that deplete surface free fatty acids, including hard water exposure.

The practical implication is that FFA depletion from external sources (hard water calcium stearate formation, alkaline surfactants) can be partially offset by supporting endogenous FFA synthesis upstream rather than supplementing lipids topically. Therapeutic doses of EPA/ DHA (2–3 g daily) are the standard reference range in barrier-focused supplementation studies. The direct evidence linking omega-3 supplementation specifically to hard water-related FFA restoration is not yet established by clinical trial – current support is mechanistic, from PPAR-α activation studies in keratinocytes and barrier lipid synthesis models – and should be framed as a logical rather than proven countermeasure. ^[3]

The IL-13/STAT6 suppression of ELOVL elongases described above and the PPAR-α synthesis pathway represent two independent regulatory points on the same output: available free fatty acid in the stratum corneum. In clients with concurrent inflammatory skin conditions and hard water exposure, both mechanisms are compromised simultaneously – making a combined approach (anti-inflammatory intervention plus omega-3 support) more rational than addressing either alone.